CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Open-market buy CEO & President bought 60,110 shares at $0.18 ($11,000)
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- 10-Q Report Quarterly Report
- DFAN14A Other Proxy Soliciting Materials
- SC 13G Stake Amended Statement of Ownership
- DEFA14A Proxy Proxy Materials
- DEFC14A Other DEFC14A
- DEFA14A Proxy Proxy Materials
- DEFC14A Other DEFC14A
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- PRRN14A Other PRRN14A
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- PREC14A Other PREC14A
- PREC14A Other PREC14A
- 8-K Event Material agreement · Unregistered share sale · Other events
Page 11 of 82 · 1,637 filings